Phage Display-Derived Cyclic Peptides as Ligand-Specific Modulators for β2-Integrin Receptors
Sommer-Pluess, C. J.; Vogt, S. A.; Ciullo, L.; Mancuso, R.; Goetze-Ebert, T.; Kehr, L.; Ricklin, D.; Lamers, C.
Show abstract
The leukocyte-specific {beta}2-integrin receptor family exerts a wide range of functions: {beta}2-integrins are involved in leukocyte trafficking, where they mediate cell adhesion during inflammatory responses via binding to ICAM-1, ICAM-2, or JAM-C. Furthermore, they are essential for the recognition and phagocytosis of pathogens opsonized by complement. Accordingly, the {beta}2-integrin family is known to be involved in autoimmune and inflammatory diseases, such as systemic lupus erythematosus. Owing to their complex biology, involving multiple conformational transitions, different signaling pathways, and a broad spectrum of ligands, the development of {beta}2-integrin-targeted probes and therapeutics has remained challenging. We aimed to develop macrocyclic peptides, derived from phage display screening, which can be used to unravel ligand binding profiles of {beta}2-integrins with an emphasis on the I domain. The selection of suitable lead peptides, and the characterization of their interaction profiles with different I domains, was enabled by an established in-vitro assay platform. Various peptide sequences were enriched during several rounds of phage display against the I-domain of CR3, of which two peptides with particularly low micromolar binding affinity were further characterized. Both peptides showed direct binding to {beta}2-integrin I-domains and, in a competitive assay, dose-dependent inhibition of the I-domains interactions with their main ligands iC3b and ICAM-1, respectively. These ligand-interfering properties were confirmed in bead- and cell-based adhesion assays. The modulators developed here are expected to provide valuable insight into the (patho-)physiology of CR3 and the other members of the {beta}2-integrin family, as the two peptides were able to compete with different ligands. In the future, this may help to identify potential therapeutic approaches for autoimmune, inflammatory, and age-related diseases.
Matching journals
The top 14 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Overcoming Ligand Discovery Challenges: Developing Peptide-Based Tracers for SPSB2 92%
- A Novel Regioselective Approach to Cyclize Phage-Displayed Peptides in Combination with Epitope-Directed Selection to Identify a Potent Neutralizing Macrocyclic Peptide for SARS-CoV-2 91%
- Characterization of a nanobody-epitope tag interaction and its application for receptor engineering 90%
Similar papers in this journal
Similar papers in this journal
- The CC′ loop of IgV domain containing immune checkpoint receptors: From a bystander to an active determinant of receptor:ligand binding 92%
- Shrimp Hemocyanin elicits a potent humoral response in mammals and is favorable to hapten conjugation 91%
- Disrupting Notch signalling by a small molecule inhibiting dihydroorotate dehydrogenase activity 90%
Similar papers in this journal
- Discovery of CD28-Targeted Small Molecule Inhibitors of T Cell Co-stimulation Using Affinity Selection-Mass Spectrometry (AS-MS) and Ex Vivo Validation 92%
- Systematic development of peptide inhibitors targeting the CXCL12/HMGB1 interaction 92%
- HighPlay：Cyclic Peptide Sequence Design Based on Reinforcement Learning and Protein Structure Prediction 92%
Similar papers in this journal
- Small-molecule inhibitors of the RNA m6A demethylase FTO potently support the survival of dopamine neurons 90%
- mRNA-LNP COVID-19 vaccine lipids induce low level complement activation and production of proinflammatory cytokines: Mechanisms, effects of complement inhibitors, and relevance to adverse reactions 90%
- Immune modulating drug MP1032 with SARS-CoV-2 antiviral activity in vitro: A potential multi-target approach for prevention and early intervention treatment of COVID-19 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.